AzTrials
AzTrials

Condition

Schizoaffective Disorder Clinical Trials

Studies of schizoaffective disorder, matched by condition name and medical subject headings. Start with those open to enrolment.

842 registered studies

In numbers

Open to volunteers
91
Active
102
With results posted
245
All registered
842

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 91
  • SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder

    Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2

    • Not yet recruiting
    • Age: 18 to 59 years
    • Lifestyle or therapy programme

    In Study 2, investigators will recruit individuals with schizophrenia (SZ) and or schizoaffective disorder (SZA) and healthy controls (HC) using optimized behavioral tasks to replicate the behavioral findings from Study 1 and to…

    Conditions
    SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder, Healthy Adult
    Trial name
    CNTRACS 2 (NCT07875790)
    Testing
    Motion Perception Task, Sine Wave Speech Task, Volatility Task
    Where
    5 sites in United States
    Volunteers
    325 people, healthy volunteers welcome
    Sponsor
    Washington University School of Medicine
    Can I take part? CNTRACS 2
  • Schizophrenia Disorder, Schizoaffective Disorder

    Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

    • Enrolling by invitation
    • Age: 18 to 65 years
    • Injection or infusion
    • Lifestyle or therapy programme

    This study is a randomized controlled trial evaluating the impact of financial incentives on medication adherence among individuals with schizophrenia, schizoaffective disorder, or bipolar disorder and/or co-occurring substance…

    Conditions
    Schizophrenia Disorder, Schizoaffective Disorder, Bipolar Disorder (BD), Substance Use Disorder (SUD)
    Trial name
    NCT07130500
    Testing
    Financial incentives for adherence to long-acting injectable medication, Standard of care with monthly surveys
    Where
    6 sites in United States
    Volunteers
    1,000 people
    Sponsor
    Stanford University
    Can I take part? NCT07130500
  • Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP)

    French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls

    • Recruiting
    • Age: 15 to 60 years
    • Surgery or procedure

    The goal of this study is to learn whether people living with severe psychiatric disorders can be grouped into more homogeneous subgroups, across usual diagnostic categories, based on two key dimensions: social withdrawal and…

    Conditions
    Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP), Bipolar Disorder (BD), Major Depressive Disorder (MDD
    Trial name
    FRENCH-MINDS (NCT07881016)
    Testing
    3T Brain MRI, Biological Sampling, Clinical, Cognitive and Digital Assessments
    Where
    17 sites in France
    Volunteers
    3,000 people, healthy volunteers welcome
    Sponsor
    Fondation FondaMental
  • Schizophenia Disorder, Severe Mental Illness

    Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness

    • Not yet recruiting
    • Age: 18 to 65 years
    • Lifestyle or therapy programme

    Severe mental illness (SMI), including schizophrenia spectrum disorders and bipolar disorder, is associated with significant impairments in psychosocial functioning, daily life participation, self-efficacy, and social…

    Conditions
    Schizophenia Disorder, Severe Mental Illness, Bipolar Disorder, Nonorganic Psychosis
    Trial name
    OT-SMI (NCT07879118)
    Testing
    Occupational Therapy Group Intervention
    Where
    Turkey (Türkiye)
    Volunteers
    50 people
    Sponsor
    Biruni University
    Can I take part? OT-SMI
  • Severe Mental Illness, Bipolar Disorder

    A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental Illness

    • Not yet recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    The goal of this clinical trial is to learn whether MoodSync, a mobile application for patients and their family caregivers, improves mood stability, medication adherence, daily functioning and early detection of relapse warning…

    Conditions
    Severe Mental Illness, Bipolar Disorder, Schizophrenia, Schizoaffective Disorder
    Trial name
    MoodSync (NCT07879131)
    Testing
    MoodSync, Standard care
    Where
    Bahrain
    Volunteers
    60 people
    Sponsor
    Alexandria University
    Can I take part? MoodSync
  • Schizophrenia Disorder, Schizoaffecitve Disorder

    DecNef for Auditory Verbal Hallucinations (AVH) in Schizophrenia

    • Not yet recruiting
    • Age: 18 to 55 years

    The purpose of this study is to learn whether a research neurofeedback training approach done during MRI scans may help reduce hallucinations such as the experience of hearing voices persistent despite treatment.

    Trial name
    DecNef (NCT07779226)
    Testing
    Decoded Neurofeedback
    Where
    2 sites in United States
    Volunteers
    51 people
    Sponsor
    Columbia University
    Can I take part? DecNef
  • Schizophrenia, Schizo Affective Disorder

    iTBS to Enhance Social Cognition in People With Psychosis

    • Recruiting
    • Age: 18 to 39 years
    • Medical device

    The goal of this clinical trial is to examine if iTBS applied to the DMPFC improves social cognitive performance compared to sham stimulation in people diagnosed with schizophrenia, schizoaffective disorder, schizophreniform…

    Conditions
    Schizophrenia, Schizo Affective Disorder, Schizophreniform Disorders, Psychosis Nos/Other
    Trial name
    iSCIP (NCT06118268)
    Testing
    iTBS (Active)
    Where
    United States
    Volunteers
    100 people
    Sponsor
    Northwell Health
    Can I take part? iSCIP
  • Schizophrenia, Schizoaffective Disorder

    NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia

    • Not yet recruiting
    • Age: 18 to 79 years
    • Medical device

    This study will examine brain metabolic and excitatory/inhibitory mechanisms related to cognitive and visual functioning in adults with schizophrenia and healthy control participants.

    Conditions
    Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment
    Trial name
    NCT07788755
    Testing
    Perceptual Discrimination Training, Cognitive Control Training
    Where
    United States
    Volunteers
    168 people, healthy volunteers welcome
    Sponsor
    University of Minnesota
  • SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder

    Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

    • Recruiting
    • Age: 18 to 59 years
    • Lifestyle or therapy programme

    In Study 1, investigators will test the ability of each of the seven paradigms to differentiate between schizophrenia (SZ)/schizoaffective disorder (SZA) and matched healthy control subjects (HC) and to predict individual…

    Conditions
    SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder, Healthy Adult Participants
    Trial name
    CNTRACS (NCT07853807)
    Testing
    Motion Perception Task, Sine Wave Speech Task, Volatility Task
    Where
    5 sites in United States
    Volunteers
    325 people, healthy volunteers welcome
    Sponsor
    Washington University School of Medicine
    Can I take part? CNTRACS
  • Schizo-affective Disorder, Non Organic Psychosis

    Motivational Intervention for Patients With Schizophrenia

    • Not yet recruiting
    • Age: 18 to 60 years
    • Lifestyle or therapy programme

    The goal of this clinical trial is to learn if a group therapy called the Positive Emotions Program for Schizophrenia (PEPS) can reduce apathy in adults aged 18 to 60 who have schizophrenia or a related psychotic disorder.

    Conditions
    Schizo-affective Disorder, Non Organic Psychosis, Schizophenia Disorder
    Trial name
    NCT07853079
    Testing
    Positive Emotion Program for Schizophrenia (PEPS), a psychotherapeutic intervention,
    Volunteers
    88 people
    Sponsor
    University of Geneva, Switzerland

Completed, with results posted

All 216
  • Schizophrenia, Schizo Affective Disorder

    Young Adults With Violent Behavior During Early Psychosis (Aim 2)

    • Completed
    • Age: 16 to 30 years
    • Lifestyle or therapy programme
    • Results posted

    This study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.

    Conditions
    Schizophrenia, Schizo Affective Disorder, Schizophreniform Disorders, Delusional Disorder
    Trial name
    NCT05756855
    Testing
    adapted behavioral intervention
    Where
    United States
    Volunteers
    12 people
    Sponsor
    Columbia University
  • Psychosis, Schizophrenia

    Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders

    • Completed
    • Age: 18 to 40 years
    • Phase 2
    • Results posted

    This clinical trial is a single center, single dose study of the acute effects of intranasal insulin on energy metabolism and cognitive function in patients with schizophrenia, schizoaffective and bipolar disorders, compared and…

    Conditions
    Psychosis, Schizophrenia, Schizo Affective Disorder, Bipolar I Disorder
    Trial name
    NCT03943537
    Testing
    Intranasal Insulin
    Where
    United States
    Volunteers
    87 people, healthy volunteers welcome
    Sponsor
    Mclean Hospital
  • Psychosis, Schizophrenia

    CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies

    • Completed
    • Age: 18 to 100 years
    • Lifestyle or therapy programme
    • Results posted

    The primary objective of this grant is to develop and evaluate an Artificial Intelligence-based clinical training tool--CBTpro--to support high-quality skills training in CBT for psychosis (CBTp).

    Conditions
    Psychosis, Schizophrenia, Schizo Affective Disorder, Bipolar Disorder
    Trial name
    CBTpro (NCT05127837)
    Testing
    CBTpro
    Where
    13 sites in United States
    Volunteers
    601 people
    Sponsor
    University of Washington
    Can I take part? CBTpro
  • Bipolar Disorder, Schizophrenia

    Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

    • Completed
    • Age: 18 to 65 years
    • Phase 4
    • Results posted

    This is an in-clinic, single arm, open-label study assessing tachyphylaxis, tolerance, and withdrawal following repeated doses of Igalmi in adult males and females with agitation associated with schizophrenia or bipolar disorder.

    Conditions
    Bipolar Disorder, Schizophrenia, Agitation,Psychomotor, Schizo Affective Disorder
    Trial name
    NCT06041646
    Testing
    Sublingual film containing Igalmi
    Where
    2 sites in United States
    Volunteers
    29 people
    Sponsor
    BioXcel Therapeutics Inc
    Can I take part? NCT06041646
  • Agitation, Schizophrenia

    Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

    • Completed
    • Age: 18 to 75 years
    • Phase 3
    • Results posted

    This is a definitive study to support the safety and efficacy evaluation of BXCL501 for the acute treatment of agitation in schizophrenia.

    Conditions
    Agitation, Schizophrenia, Schizo Affective Disorder, Schizoaffective Disorder
    Trial name
    SERENITY I (NCT04268303)
    Testing
    Sublingual film containing dexmedetomidine (BXCL501)
    Where
    15 sites in United States
    Volunteers
    380 people
    Sponsor
    BioXcel Therapeutics Inc
    Can I take part? SERENITY I

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in